id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0151-0003,FDA,FDA-2002-N-0151,Agency Information Collection Activities; Announcement of OMB Approval; Notice of Participation,Notice,Notice of Approval,2003-04-20T04:00:00Z,2003,4,2003-04-21T04:00:00Z,,2025-05-08T16:26:51Z,03-9662,0,0,09000064804929b7
FDA-2002-N-0151-0002,FDA,FDA-2002-N-0151,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of Participation,Notice,General Notice,2002-12-29T05:00:00Z,2002,12,2002-12-30T05:00:00Z,2003-01-30T04:59:59Z,2025-05-08T16:21:48Z,02-32849,0,0,09000064804929ab
FDA-2002-N-0151-0001,FDA,FDA-2002-N-0151,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation,Notice,General Notice,2002-07-21T04:00:00Z,2002,7,2002-07-18T04:00:00Z,2002-09-17T03:59:59Z,2025-05-08T16:08:26Z,02-18122,0,0,0900006480492968